YJ, Z., HL, W., WL, A., SH, S., N, L., SC, L., & LC, T. (2011). Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. Parkinsonism & Related Disorders, 17(3), 194. https://doi.org/10.1016/j.parkreldis.2010.11.010
Chicago Style (17th ed.) CitationYJ, Zhao, Wee HL, Au WL, Seah SH, Luo N, Li SC, and Tan LC. "Selegiline Use Is Associated with a Slower Progression in Early Parkinson's Disease as Evaluated by Hoehn and Yahr Stage Transition Times." Parkinsonism & Related Disorders 17, no. 3 (2011): 194. https://doi.org/10.1016/j.parkreldis.2010.11.010.
MLA (9th ed.) CitationYJ, Zhao, et al. "Selegiline Use Is Associated with a Slower Progression in Early Parkinson's Disease as Evaluated by Hoehn and Yahr Stage Transition Times." Parkinsonism & Related Disorders, vol. 17, no. 3, 2011, p. 194, https://doi.org/10.1016/j.parkreldis.2010.11.010.